Q&A Zealand Pharma 2019-12-03
Aktiesnakken
Genmab
NOVO
Zealand Pharma
Shipping
Bavarian Nordic
Chemometec
Gubra
Amerikanske aktier
AMBU
Biotek-snakken
TESLA
Grønne Aktier
Medico
Pharma
Smallcap og First North aktier
Banker og Finans
GN Store Nord
Hansa Biopharma
Laks
EL-BILER
ExpreS2ion
Krypto
BITCOIN
Ennogie
Vestas
3/12 17:10 af Emmanuel Dulac |
Zealand Pharma has made impressive progress so far this year! We were thrilled with the results from the pediatric study in the Phase 3 clinical program for dasiglucagon HypoPal, which concluded the clinical program and we have full focus on preparing the NDA to submit early next year...
| |
3/12 17:09 af Helge Larsen/PI-redaktør |
Can you please give us a short-term update on key figures and important events for Q3.
| |
3/12 17:08 af Helge Larsen/PI-redaktør |
Good afternoon, Emmanuel Dulac and welcome to Q&A with us here on ProInvestor.com. We are very happy to have you with us today - ready to answer a wide variety of questions from our investors.
| |
3/12 17:08 af Emmanuel Dulac |
I am finally online now
| |
3/12 17:07 af Helge Larsen/PI-redaktør |
Great.
| |
3/12 17:07 af Emmanuel Dulac |
Hello
| |
3/12 16:58 af Helge Larsen/PI-redaktør |
Emmanuel Dulac, are you online?
| |
3/12 16:04 af Helge Larsen/PI-redaktør |
Q&A starter i dag kl. 16.
|